News & Updates
Filter by Specialty:
On-body injector on par with traditional injection in preventing severe neutropaenia
Pegfilgrastim on-body injectors (OBI) are as effective as traditional injection for the prevention of severe neutropaenia (SN), neutropaenic fever, and neutropaenia in breast cancer patients, reveals a study.
On-body injector on par with traditional injection in preventing severe neutropaenia
05 Feb 2022
Early multimorbidity associated with dementia
A prospective cohort study of over 10,000 participants followed up for more than 30 years finds a robust association between midlife-onset multimorbidity and subsequent dementia.
Early multimorbidity associated with dementia
05 Feb 2022
Obese breast cancer patients on T-DM1 prone to more treatment adjustments
More treatment modifications secondary to adverse events appear necessary among obese patients receiving ado-trastuzumab emtansine (T-DM1), an antibody-drug conjugate indicated for the treatment of HER2-positive breast cancer, relative to nonobese counterparts, reports a study.
Obese breast cancer patients on T-DM1 prone to more treatment adjustments
04 Feb 2022
Systemic inflammation mediates obesity-related severe COVID-19
Systemic inflammation plays a significant role in severe COVID-19 associated with obesity, particularly in patients aged <65 years, as captured by peak C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR), a study has found.
